Ethnicity, socioeconomic status, and attainment of clinical practice guideline standards in dialysis patients in the United Kingdom

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 5, 2009, Pages 979-987

  Udayaraj, Udaya P ^a   Ben Shlomo, Yoav ^b   Roderick, Paul ^c   Steenkamp, Retha ^a   Ansell, David ^a   Tomson, Charles R V ^a   Caskey, Fergus J ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM PHOSPHATE; HEMOGLOBIN; PARATHYROID HORMONE; PHOSPHATE; PTH PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ETHNICITY; FEMALE; HEALTH CARE SYSTEM; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PRACTICE GUIDELINE; SOCIAL STATUS; SOUTH ASIA; STANDARD; UNITED KINGDOM; ADOLESCENT; ASIAN; BLOOD; CAUCASIAN; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; ETHNOLOGY; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; METABOLISM; MIDDLE AGED; NEGRO; REGISTER; RENAL REPLACEMENT THERAPY; SOCIAL CLASS; STATISTICS;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GREAT BRITAIN; GUIDELINE ADHERENCE; HEALTH SERVICES ACCESSIBILITY; HEMOGLOBINS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; REGISTRIES; RENAL DIALYSIS; SOCIAL CLASS; YOUNG ADULT;

EID: 68549098261     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06311208     Document Type: Article

References (56)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39: S1-S266, 2002
2. Renal Association. Treatment of adults and children with renal failure. Standards and audit measures. London, UK, Royal College of Physicians, 2002
3. Obrador GT, Ruthazer R, Arora P, Kausz AT, Pereira BJ: Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol 10: 1793-1800, 1999
4. Ward MM: Laboratory abnormalities at the onset of treatment of end-stage renal disease: Are there racial or socioeconomic disparities in care? Arch Intern Med 167: 1083-1091, 2007
5. Frankenfield DL, Rocco MV, Frederick PR, Pugh J, McClellan WM, Owen, WF, Jr.: Racial/ethnic analysis of selected intermediate outcomes for hemodialysis patients: Results from the 1997 ESRD Core Indicators Project. Am J Kidney Dis 34: 721-730, 1999
6. Gupta A, Kallenbach LR, Zasuwa G, Divine GW: Race is a major determinant of secondary hyperparathyroidism in uremic patients. J Am Soc Nephro 11: 330-334, 2000
7. Frankenfield DL, Ramirez SP, McClellan WM, Frederick PR, Rocco MV: Differences in intermediate outcomes for Asian and non-Asian adult hemodialysis patients in the United States. Kidney Int 64: 623-631, 2003
8. Caskey FJ, Roderick P, Steenkamp R, Nitsch D, Thomas K, Ansell D, Feest T: Social deprivation and survival on renal replacement therapy in England and Wales. Kidney Int 70: 2134-2140, 2006
9. Isaacs RB, Nock SL, Spencer CE, Connors AF, Jr., Wang XQ, Sawyer R, Lobo PI: Racial disparities in renal transplant outcomes. Am J Kidney Dis 34: 706-712, 1999
10. Curtis JJ: Kidney transplantation: Racial or socioeconomic disparities? Am J Kidney Dis 34: 756-758, 1999
11. Press R, Carrasquillo O, Nickolas T, Radhakrishnan J, Shea S, Barr RG: Race/ethnicity, poverty status, and renal transplant outcomes. Transplantation 80: 917-924, 2005
12. Pallet N, Thervet E, Alberti C, Emal-Aglae V, Bedrossian J, Martinez F, Roy C, Legendre C: Kidney transplant in black recipients: Are African Europeans different from African Americans? Am J Transplant 5: 2682-2687, 2005
13. Port FK, Wolfe RA, Levin NW, Guire KE, Ferguson CW: Income and survival in chronic dialysis patients. ASAIO Trans 36: M154-M157, 1990
14. Borrell LN, Dallo FJ, White K: Education and diabetes in a racially and ethnically diverse population. Am J Public Health 96: 1637-1642, 2006
15. Bhopal R, Hayes L, White M, Unwin N, Harland J, Ayis S, Alberti G: Ethnic and socio-economic inequalities in coronary heart disease, diabetes and risk factors in Europeans and South Asians. J Public Health Med 24: 95-105, 2002
16. Albano JD, Ward E, Jemal A, Anderson R, Cokkinides VE, Murray T, Henley J, Liff J, Thun MJ: Cancer mortality in the United States by education level and race. J Natl Cancer Inst 99: 1384-1394, 2007
17. Gilman SE, Breslau J, Conron KJ, Koenen KC, Subramanian SV, Zaslavsky AM: Education and race-ethnicity differences in the lifetime risk of alcohol dependence. J Epidemiol Community Health 62: 224-230, 2008
18. Smith LA, Hatcher-Ross JL, Wertheimer R, Kahn RS: Rethinking race/ethnicity, income, and childhood asthma: Racial/ethnic disparities concentrated among the very poor. Public Health Rep 120: 109-116, 2005
19. Ansell D, Feest, T: The sixth annual report. Chapter 2: Introduction to the 2003 report. Bristol, UK Renal Registry, 2003, pp 3-14
20. Nanchahal K, Mangtani P, Alston M, dos Santos Silva I: Development and validation of a computerized South Asian Names and Group Recognition Algorithm (SANGRA) for use in British health-related studies. J Public Health Med 23: 278-285, 2001
21. Raleigh VS: Diabetes and hypertension in Britain's ethnic minorities: Implications for the future of renal services. BMJ 314: 209-213, 1997
22. Roderick PJ, Raleigh VS, Hallam L, Mallick NP: The need and demand for renal replacement therapy in ethnic minorities in England. J Epidemiol Community Health 50: 334-339, 1996
23. Townsend P, Phillimore P, Beattie A: Health and Deprivation: Inequality and the North, London, Croom Helm, 1988
24. Ansell D, Feest, T: The sixth annual report. Chapter 17: Social deprivation on renal replacement therapy. Bristol, UK Renal Registry, 2003, pp 257-272
25. Ansell D, Feest T: The seventh annual report. Chapter 9: Serum phosphate, calcium, parathyroid hormone and albumin. Bristol, UK Renal Registry, 2004, pp 123-135
26. Collins AJ, Ma JZ, Xia A, Ebben J: Trends in anemia treatment with erythropoietin usage and patient outcomes. Am J Kidney Dis 32: S133-S141, 1998
27. Locatelli F, Conte F, Marcelli D: The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity-The experience of the Lombardy Dialysis Registry. Nephrol Dial Transplant 13: 1642-1644, 1998
28. Beusterien KM, Nissenson AR, Port FK, Kelly M, Steinwald B, Ware JE, Jr.: The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients. J Am Soc Nephrol 7: 763-773, 1996
29. Laupacis A: Changes in quality of life and functional capacity in hemodialysis patients treated with recombinant human erythropoietin. The Canadian Erythropoietin Study Group. Semin Nephro 10: 11-19, 1990
30. Ansell D, Feest T: The sixth annual report: Analysis of characteristics and survival of incident patients from different ethnic groups starting renal replacement therapy. Bristol, UK Renal Registry, pp 317-329, 2003
31. Pei YP, Greenwood CM, Chery AL, Wu GG: Racial differences in survival of patients on dialysis. Kidney Int 58: 1293-1299, 2000
32. Hicks LS, Cleary PD, Epstein AM, Ayanian JZ: Differences in health-related quality of life and treatment preferences among black and white patients with end-stage renal disease. Qual Life Res 13: 1129-1137, 2004
33. Unruh M, Miskulin D, Yan G, Hays RD, Benz R, Kusek JW, Meyer KB: Racial differences in health-related quality of life among hemodialysis patients. Kidney Int 65: 1482-1491, 2004
34. Jones-Burton C, Seliger SL, Brown J, Stackiewicz L, Hsu VD, Fink JC: Racial variations in erythropoietic response to epoetin alfa in chronic kidney disease and the impact of smoking. Nephrol Dial Transplant 20: 2739-2745, 2005
35. Bleyer AJ, Hylander B, Sudo H, Nomoto Y, de la Torre E, Chen RA, Burkart JM: An international study of patient compliance with hemodialysis. JAMA 281: 1211-1213, 1999
36. Wolfe RA, Ashby VB, Daugirdas JT, Agodoa LY, Jones CA, Port FK: Body size, dose of hemodialysis, and mortality. Am J Kidney Dis 35: 80-88, 2000
37. Deurenberg P, Yap M, van Staveren WA: Body mass index and percent body fat: A meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 22: 1164-1171, 1998
38. Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y: Healthy percentage body fat ranges: An approach for developing guidelines based on body mass index. Am J Clin Nutr 72: 694-701, 2000
39. Palep-Singh M, Picton HM, Barth JH, Balen AH: Ethnic variations in the distribution of obesity and biochemical metabolic abnormalities in fertility clinic attendees. J Reprod Med 53: 117-1123, 2008
40. Siervo M, Davies AA, Jebb SA, Jalil F, Moore SE, Prentice AM: Ethnic differences in the association between body mass index and impedance index (Ht2/Z) in adult women and men using a leg-to-leg bioimpedance method. Eur J Clin Nutr 61: 1337-4130, 2007
41. Sawaya BP, Monier-Faugere MC, Ratanapanichkich P, Butros R, Wedlund PJ, Fanti P: Racial differences in parathyroid hormone levels in patients with secondary hyperparathyroidism. Clin Nephrol 57: 51-55, 2002
42. Ghandur-Mnaymneh L, Cassady J, Hajianpour MA, Paz J, Reiss E: The parathyroid gland in health and disease. Am J Pathol 125: 292-299, 1986
43. Serhan E, Holland MR: Relationship of hypovitaminosis D and secondary hyperparathyroidism with bone mineral density among UK resident Indo-Asians. Ann Rheum Dis 61: 456-458, 2002
44. Bell NH, Yergey AL, Vieira NE, Oexmann MJ, Shary JR: Demonstration of a difference in urinary calcium, not calcium absorption, in black and white adolescents. J Bone Miner Res 8: 1111-1115, 1993
45. Bell NH, Greene A, Epstein S, Oexmann MJ, Shaw S, Shary J: Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest 76: 470-473, 1985
46. Hustmyer FG, DeLuca HF, Peacock M: ApaI, BsmI, EcoRV and TaqI polymorphisms at the human vitamin D receptor gene locus in Caucasians, blacks and Asians. Hum Mol Genet 2: 487, 1993
47. Yokoyama K, Shigematsu T, Tsukada T, Ogura Y, Takemoto F, Hara S, Yamada A, Kawaguchi Y, Hosoya T: ApaI polymorphism in the vitamin D receptor gene may affect the parathyroid response in Japanese with end-stage renal disease. Kidney Int 53: 454-458, 1998
48. Cosman F, Morgan DC, Nieves JW, Shen V, Luckey MM, Dempster DW, Lindsay R, Parisien M: Resistance to bone resorbing effects of PTH in black women. J Bone Miner Res 12: 958-966, 1997
49. Fuleihan GE, Gundberg CM, Gleason R, Brown EM, Stromski ME, Grant FD, Conlin PR: Racial differences in parathyroid hormone dynamics. J Clin Endocrinol Metab 79: 1642-1647, 1994
50. Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Juppner H, Wolf M: Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359: 584-592, 2008
51. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218, 2004
52. Slinin Y, Foley RN, Collins AJ: Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: The USRDS waves 1, 3, and 4 study. J Am Soc Nephrol 16: 1788-1793, 2005
53. Sawaya BP, Butros R, Naqvi S, Geng Z, Mawad H, Friedler R, Fanti P, Monier-Faugere MC, Malluche HH: Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease. Kidney Int 64: 737-742, 2003
54. Cantor TL: iPTH treatment guidelines for Caucasian versus African-American hemodialysis patients. Semin Dial 20: 370-371, 2007
55. Gupta A: Renal bone disease in black dialysis patients: Are algorithms developed for white dialysis patients valid? Nephrol Dial Transplant 16: 1518-1519, 2001
56. Hemmelgarn BR, Chou S, Wiebe N, Culleton BF, Manns BJ, Klarenbach S, Khan NA, Gourishankar S, Yeates KE, Gill JS, Tonelli M: Differences in use of peritoneal dialysis and survival among East Asian, Indo Asian, and white ESRD patients in Canada. Am J Kidney Dis 48: 964 -971, 2006